JKJavier Yu Peng Koh

Javier Yu Peng Koh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Javier Yu Peng Koh has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Koji Itahana

    Programme in Cancer and Stem Cell Biology Duke‐NUS Medical School Singapore

    3 shared publications
  • Yoko Itahana

    Cancer and Stem Cell Biology Programme, Duke-NUS Medical School

    3 shared publications
  • Aaron Trent Irving

    Affiliations Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Centre for Infection, Immunity & Cancer, Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Haining, China, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom, Biomedical and Health Translational Research Centre of Zhejiang Province, Haining, China

    2 shared publications
  • Lin-Fa Wang

    Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore

    2 shared publications
  • Lisa Tucker-Kellogg

    Critical Analytics for Manufacturing Personalised-medicine (CAMP) Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology (SMART) Centre, Singapore, Republic of Singapore

    2 shared publications
  • Narendra Suhas Jagannathan

    Cancer and Stem Cell Biology Programme, Duke-NUS Medical School

    2 shared publications

Latest Publications

  • Open Access

    Multi-omic analysis of bat versus human fibroblasts reveals altered central metabolism

    by N Suhas Jagannathan, Javier Yu Peng Koh, Younghwan Lee, Radoslaw Mikolaj Sobota, Aaron T Irving, Lin-Fa Wang, Yoko Itahana, Koji Itahana, Lisa Tucker-Kellogg

    Bats have unique characteristics compared to other mammals, including increased longevity and higher resistance to cancer and infectious disease. While previous studies have analyzed the metabolic requirements for flight, it is still unclear how bat metabolism supports these unique features, and no study has integrated metabolomics, transcriptomics, and proteomics to characterize bat metabolism. In this work, we performed a multi-omics data analysis using a computational model of metabolic fluxes to identify fundamental differences in central metabolism between primary lung fibroblast cell lines from the black flying fox fruit bat (Pteropus alecto) and human. Bat cells showed higher expression levels of Complex I components of electron transport chain (ETC), but, remarkably, a lower rate of oxygen consumption. Computational modeling interpreted these results as indicating that Complex II activity may be low or reversed, similar to an ischemic state. An ischemic-like state of bats was also supported by decreased levels of central metabolites and increased ratios of succinate to fumarate in bat cells. Ischemic states tend to produce reactive oxygen species (ROS), which would be incompatible with the longevity of bats. However, bat cells had higher antioxidant reservoirs (higher total glutathione and higher ratio of NADPH to NADP) despite higher mitochondrial ROS levels. In addition, bat cells were more resistant to glucose deprivation and had increased resistance to ferroptosis, one of the characteristics of which is oxidative stress. Thus, our studies revealed distinct differences in the ETC regulation and metabolic stress responses between human and bat cells.


  • Open Access

    Exploring bat-inspired cyclic tryptophan diketopiperazines as ABCB1 Inhibitors

    by Javier Yu Peng Koh, Yoko Itahana, Alexander Krah, Habib Mostafa, Mingmin Ong, Sahana Iwamura, Dona Mariya Vincent, Sabhashina Radha Krishnan, Weiying Ye, Pierre Wing Chi Yim, et al.

    Chemotherapy-induced drug resistance remains a major cause of cancer recurrence and patient mortality. ATP binding cassette subfamily B member 1 (ABCB1) transporter overexpression in tumors contributes to resistance, yet current ABCB1 inhibitors have been unsuccessful in clinical trials. To address this challenge, we propose a new strategy using tryptophan as a lead molecule for developing ABCB1 inhibitors. Our idea stems from our studies on bat cells, as bats have low cancer incidences and high ABCB1 expression. We hypothesized that potential ABCB1 substrates in bats could act as competitive inhibitors in humans. By molecular simulations of ABCB1-substrate interactions, we generated a benzylated Cyclo-tryptophan (C3N-Dbn-Trp2) that inhibits ABCB1 activity with efficacy comparable to or better than the classical inhibitor, verapamil. C3N-Dbn-Trp2 restored chemotherapy sensitivity in drug-resistant human cancer cells with no adverse effect on cell proliferation. Our unique approach presents a promising lead toward developing effective ABCB1 inhibitors to treat drug-resistant cancers.


  • Open Access

    Multi-omic analysis of bat versus human fibroblasts reveals altered central metabolism

    by N. Suhas Jagannathan, Javier Yu Peng Koh, Younghwan Lee, Radoslaw M Sobota, Aaron Irving, Lin-Fa Wang, Yoko Itahana, Koji Itahana, Lisa Tucker-Kellogg

    Bats have unique characteristics compared to other mammals, including increased longevity and higher resistance to cancer and infectious disease. While previous studies have analyzed the metabolic requirements for flight, it is still unclear how bat metabolism supports these unique features, and no study has integrated metabolomics, transcriptomics, and proteomics to characterize bat metabolism. In this work, we performed a multi-omics data analysis using a computational model of metabolic fluxes to identify fundamental differences in central metabolism between primary lung fibroblast cell lines from the black flying fox fruit bat ( Pteropus alecto ) and human. Bat cells showed higher expression levels of Complex I components of electron transport chain (ETC), but, remarkably, a lower rate of oxygen consumption (OCR). Computational modeling interpreted these results as indicating that Complex II activity may be low or reversed, similar to an ischemic state. An ischemic-like state of bats was also supported by decreased levels of central metabolites and increased ratios of succinate to fumarate in bat cells. Ischemic states tend to produce reactive oxygen species (ROS), which would be incompatible with the longevity of bats. However, bat cells had higher antioxidant reservoirs (higher total glutathione and higher ratio of NADPH to NADP) despite higher mitochondrial ROS levels. In addition, bat cells were more resistant to glucose deprivation and had increased resistance to ferroptosis, one of the characteristics of which is oxidative stress. Thus, our studies revealed distinct differences in the ETC regulation and metabolic stress responses between human and bat cells.